Recruiting × Small Cell Lung Carcinoma × Thoracic × Clear all A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
Phase 1 Recruiting
453 enrolled
A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
Phase 1 Recruiting
30 enrolled
DeLLphi-312
Phase 3 Recruiting
330 enrolled
A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
Phase 1 Recruiting
76 enrolled
DeLLphi-306
Phase 3 Recruiting
400 enrolled
A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer
Phase 1/2 Recruiting
594 enrolled
A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
Phase 1/2 Recruiting
150 enrolled
Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
Recruiting
2,000 enrolled
SEZanne
Phase 2 Recruiting
180 enrolled
Cardiopulmonary Exercise Testing in Lung Cancer Patients Before and During Oncological Treatment
Recruiting
90 enrolled
KEYNOTE-B98
Phase 1/2 Recruiting
110 enrolled
MK-6070-002
Phase 1/2 Recruiting
262 enrolled
PrE0510
Phase 2 Recruiting
60 enrolled
Phase II Study of Sacituzumab Govitecan With Atezolizumab/Durvalumab as Maintenance Therapy for Extensive-Stage Small Cell Lung Cancer
Phase 2 Recruiting
35 enrolled
A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
Phase 1/2 Recruiting
118 enrolled
Temozolomide and Atezolizumab for Subsequent Line for the Treatment of Metastatic or Recurrent Small Cell Lung Cancer
Phase 2 Recruiting
56 enrolled
Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
Phase 2/3 Recruiting
550 enrolled
Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
Phase 1/2 Recruiting
138 enrolled
Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
Phase 2 Recruiting
40 enrolled
Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors
Phase 1 Recruiting
40 enrolled
A Study of SGN-CEACAM5C in Adults With Advanced Solid Tumors
Phase 1 Recruiting
914 enrolled
Phase I Study of SYS6043 in Patients With Advanced/Metastatic Solid Tumors
Phase 1 Recruiting
386 enrolled
Testing if High Dose Radiation Only to the Sites of Brain Cancer Compared to Whole Brain Radiation That Avoids the Hippocampus is Better at Preventing Loss of Memory and Thinking Ability
Phase 3 Recruiting
200 enrolled
Safety and Efficacy Evaluation of Serplulimab Plus Chemo in SCLC Transformed From EGFR-mutated NSCLC After Treatment
Phase 2 Recruiting
36 enrolled
A Study to Compare the Efficacy and Safety of BMS-986489 (BMS-986012+ Nivolumab Fixed Dose Combination) in Combination With Carboplatin Plus Etoposide to That of Atezolizumab With Carboplatin Plus Etoposide as First-Line Therapy in Participants With Extensive-Stage Small Cell Lung Cancer (TIGOS).
Phase 3 Recruiting
530 enrolled
MDT-Based Umbrella Decision Model for Geriatric Lung Cancer Patients
Phase NA Recruiting
2,000 enrolled
IKF-ReWoLuTe
Recruiting
240 enrolled
TEMPUS Small Cell Lung Cancer OBSERVATIONAL STUDY (Sculptor)
Recruiting
200 enrolled
Relief
Phase 3 Recruiting
121 enrolled
SKB500 Combinations in Patients With Small Cell Lung Cancer
Phase 2 Recruiting
80 enrolled
68Ga-PFD3 PET Imaging for the Diagnosis and Evaluation of Small Cell Lung Cancer
Phase 1/2 Recruiting
30 enrolled
A Study of Valemetostat in Combination With Atezolizumab in People With Lung Cancer
Phase 1 Recruiting
24 enrolled
ESCALADOR
Phase 3 Recruiting
300 enrolled
DP-04
Recruiting
100 enrolled
Study of Trilaciclib and Lurbinectidin
Phase 2 Recruiting
30 enrolled
Phase 2 Study of Fingolimod in Lung Cancers
Phase 2 Recruiting
38 enrolled
Using Biomarker Tests to Select and Test New, Personalized Treatments for Extensive Stage Small Cell Lung Cancer, PRISM Study
Phase 2 Recruiting
900 enrolled
18F-Fibroblast Activation Protein Inhibitor ([18F]FAPI-74) PET Imaging for Cancer Detection
Phase 2 Recruiting
320 enrolled
A Study of Hospital-at-Home for People Receiving Tarlatamab
Phase NA Recruiting
70 enrolled
Durvalumab as Consolidation for Patients LS-SCLC
Phase 2 Recruiting
100 enrolled
BetaBart
Phase 1/2 Recruiting
61 enrolled
ALBORAN
Phase 3 Recruiting
70 enrolled
Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
Phase 1 Recruiting
116 enrolled
Lurbinectedin With or Without Avelumab in Small Cell Carcinoma of the Bladder (LASER)
Phase 2 Recruiting
45 enrolled
AVA6103 in Subjects With Locally Advanced or Metastatic Selected Solid Tumors
Phase 1 Recruiting
144 enrolled
DART-NK-SCLC
Phase 1/2 Recruiting
60 enrolled
DLLEVATE
Phase 3 Recruiting
480 enrolled
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
Phase 1/2 Recruiting
300 enrolled
Relapsed SCLC
Phase 1/2 Recruiting
166 enrolled
A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination With Nivolumab in Participants With Relapsed/Refractory Small Cell Lung Cancer
Phase 1/2 Recruiting
240 enrolled